Pharmacokinetics of a new fentanyl tape with a novel delivery system of transdermal matrix patches in patients with cancer pain.

Abstract:

OBJECTIVES:A novel delivery system for transdermal matrix patches of fentanyl has been developed. The new fentanyl tape consists of a backing layer, a drug-containing layer and a release liner that is originally made of rubber adhesive. This open-label prospective study investigated the pharmacokinetics and safety of the fentanyl tape in patients with cancer pain. METHODS:The tape was applied to the patient's chest for 72 h, and serum samples were collected from 0 to 72 h. Fentanyl concentrations were determined using liquid chromatography with mass spectrometry. Pharmacokinetic parameters were calculated, and adverse events were evaluated according to the Common Terminology Criteria for Adverse Events (version 3.0). RESULTS:Since 1 patient treated with 2.1 mg fentanyl was found to represent unique pharmacokinetic parameters by Shapiro-Wilk test, only 15 of the 16 study patients were investigated. Maximum serum concentrations (Cmax) and area under the curve (AUC)0-72 at 2.1 and 4.2 mg were 0.26 and 0.35 ng/ml, and 11.58 and 15.95 ng·h/ml, respectively. The Cmax and AUC0-72 tended to increase with dosage from 2.1 to 4.2 mg. There were no grade 3 toxicities, and only grade 1 ALT and AST elevations were observed. CONCLUSION:The novel delivery system of fentanyl may be a very promising approach to manage cancer pain clinically.

journal_name

Oncology

journal_title

Oncology

authors

Saito T,Fujii M,Saito S,Shimada K,Fujiwara K,Kobayashi K

doi

10.1159/000356625

subject

Has Abstract

pub_date

2014-01-01 00:00:00

pages

10-5

issue

1

eissn

0030-2414

issn

1423-0232

pii

000356625

journal_volume

86

pub_type

临床试验,杂志文章

相关文献

ONCOLOGY文献大全
  • In vitro and in vivo growth inhibition of SC-M1 gastric cancer cells by retinoic acid.

    abstract::Retinoids are differentiating agents that have been used successfully for the treatment of acute promyelocytic leukemia. When combined with interferons, they are active in preventing second malignancies in patients with head and neck cancer. Our previous studies have demonstrated cytostatic effects of alltrans-retinoi...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227583

    authors: Jiang SY,Shyu RY,Chen HY,Lee MM,Wu KL,Yeh MY

    更新日期:1996-07-01 00:00:00

  • Oral medium-dosed metoclopramide versus placebo as highly effective antiemetic prophylaxis in in- and outpatients on noncisplatin chemotherapy.

    abstract::The antiemetic effect of oral medium-dosed metoclopramide (MCL, 3.5 mg/kg b.w./cycle) and placebo for chemotherapy-induced emesis of a noncisplatin regimen was assessed for inpatients and outpatients in two double-blind placebo-controlled sequential analyses according to Bross (1952). MCL was given in 5 single doses o...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000227153

    authors: Vogt C,Hellenbrecht D,Saller R,Achtert G,Brockmann P,Hausleiter H

    更新日期:1993-03-01 00:00:00

  • Prolonged administration of oral etoposide plus cisplatin in extensive stage small cell lung cancer.

    abstract::Etoposide is a highly schedule-dependent agent. We previously reported that a 21-day schedule of oral etoposide had good activity in small cell lung cancer (SCLC). The current phase II study was designed to test the combination of 21-day oral etoposide with cisplatin in hopes of capitalizing on etoposide's schedule de...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227108

    authors: Greco FA,Murphy PB,Hainsworth JD,Hande KR,Johnson DH

    更新日期:1992-01-01 00:00:00

  • A phase II study of carboplatin in nasopharyngeal carcinoma.

    abstract::This is a phase II study to evaluate the efficacy and toxicity of short-course carboplatin in advanced-stage nasopharyngeal carcinoma (NPC). Thirty-three previously untreated stage III-IV NPC patients were studied. Carboplatin was given as a rapid intravenous injection every 3 weeks. The dose of carboplatin was calcul...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227689

    authors: Chi KH,Chang YC,Chan WK,Liu JM,Law CK,Lo SS,Shu CH,Yen SH,Whang-Peng J,Chen KY

    更新日期:1997-05-01 00:00:00

  • Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival.

    abstract:OBJECTIVES:Anaplastic oligodendrogliomas (AO) are uncommon primary brain tumors whose natural history, prognosis, and optimal management are not yet fully understood. However, they are associated with a better prognosis and response to multimodality therapy based on specific molecular changes. In this multicenter retro...

    journal_title:Oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1159/000074479

    authors: Puduvalli VK,Hashmi M,McAllister LD,Levin VA,Hess KR,Prados M,Jaeckle KA,Yung WK,Buys SS,Bruner JM,Townsend JJ,Davis R,Sawaya R,Kyritsis AP

    更新日期:2003-01-01 00:00:00

  • Immunohistological approach to tumor diagnosis.

    abstract::Immunoperoxidase methods permit the demonstration of a variety of antigens in routinely processed tissues. The morphological detail obtained by this procedure is comparable to orthodox haematoxylin and eosin stained sections, and so offers the diagnostic pathologist the opportunity of simultaneously identifying normal...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:

    authors: Taylor CR

    更新日期:1978-01-01 00:00:00

  • Phase II study of UFT plus leucovorin in colorectal cancer.

    abstract::The activity and toxicity of UFT (Tegafur and Uracil) in a 4:1 molar concentration, plus leucovorin (LV), were evaluated in the treatment of 45 patients with advanced, bidimensionally measurable metastatic colorectal carcinoma. Initially 350 and later 300 mg/m2/day, plus 150 mg LV, as administered in divided doses eve...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227741

    authors: Pazdur R

    更新日期:1997-01-01 00:00:00

  • Circulating and disseminated tumor cells in the clinical management of breast cancer patients: unanswered questions.

    abstract::Breast cancer is the most common cancer in women. Although survival rates have improved with the use of new therapeutic agents, many issues remain unresolved and new predictive and prognostic factors are needed in clinical practice. Several studies have suggested a prognostic and predictive role for circulating and di...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000215581

    authors: Amadori A,Rossi E,Zamarchi R,Carli P,Pastorelli D,Jirillo A

    更新日期:2009-01-01 00:00:00

  • Antiemetic study methodology: recommendations for future studies.

    abstract::The methodology of future antiemetic studies will reflect the need to address the problems identified in current studies. New preclinical information on the mechanisms of emesis and antiemetic action will allow more rational clinical study design. Prior to large randomized studies, phase I and II trials should define ...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000227648

    authors: Olver IN

    更新日期:1996-06-01 00:00:00

  • Bile acid load on the DNA distribution pattern of bile ductules and cholangiocarcinoma induced by diisopropanolnitrosamine in hamsters.

    abstract::This study evaluated the influence of bile acid load on the DNA distribution pattern of proliferated bile ductules and cholangiocarcinoma induced by diisopropanolnitrosamine. Ninety hamsters were separated into control, tauro- and deoxycholic acid (DCA) groups. The DNA distribution pattern of intrahepatic lesions at 1...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000011839

    authors: Kinami Y,Miyakoshi M,Fujikawa K

    更新日期:1998-01-01 00:00:00

  • Testicular lymphoma: organ-specific treatment did not improve outcome.

    abstract:OBJECTIVES:To assess whether the use of an organ-specific treatment could improve event-free survival (EFS) and overall survival as endpoints in testicular lymphoma in the early stage: IE and IIE. METHODS:Thirty-four patients were selected to be treated with orchiectomy following six cycles of anthracycline-based comb...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000081319

    authors: Avilés A,Neri N,Huerta-Guzmán J,Pérez F,Fernández R

    更新日期:2004-01-01 00:00:00

  • Accumulation of 111In-bleomycin in metastatic lesions from carcinoma of the uterine cervix and the ovary.

    abstract::Cases are presented in which 111In-bleomycin accumulated in Virchow's gland metastasis from squamous cell carcinoma of the uterine cervix, and in paratracheal lymphatic gland metastasis from embryonal carcinoma of the right ovary. Thus, this radiopharmaceutical was found to be of great use for assessment of metastatic...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226373

    authors: Kida T,Ikeda M

    更新日期:1986-01-01 00:00:00

  • Preoperative predictors for residual tumor after surgery in patients with ovarian carcinoma.

    abstract:OBJECTIVES:Suboptimal debulking (>1 cm residual tumor) results in poor survival rates for patients with an advanced stage of ovarian cancer. The purpose of this study was to develop a prediction model, based on simple preoperative parameters, for patients with an advanced stage of ovarian cancer who are at risk of subo...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000113051

    authors: de Jong D,Eijkemans MJ,Lie Fong S,Gerestein CG,Kooi GS,Baalbergen A,van der Burg ME,Burger CW,Ansink AC

    更新日期:2007-01-01 00:00:00

  • Acute leukemia following chemotherapy and radiation therapy--a report of 15 cases.

    abstract::14 patients developed acute nonlymphocytic leukemia and 1 patient developed Burkitt's leukemia following longterm chemotherapy and/or radiotherapy for other disorders. The main primary disorders included multiple myeloma, Hodgkin's disease, non-Hodgkin's lymphoma and breast carcinoma. Acute leukemia developed earlier ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225798

    authors: Brenner B,Carter A,Sharon R,Tatarsky I

    更新日期:1984-01-01 00:00:00

  • The synergistic effect of 5-aza-2'-deoxycytidine and 5-fluorouracil on drug-resistant tumors.

    abstract:PURPOSE:We investigated whether a 5-fluorouracil (5-FU)-resistant tumor could regain chemosensitivity after the administration of 5-aza-2'-deoxycytidine (DAC) as a demethylating agent. METHODS:Human colorectal cancer cells (SW48) are characterized by the hypermethylation of proapoptotic genes. They were transplanted i...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000107110

    authors: Morita S,Iida S,Kato K,Takagi Y,Uetake H,Sugihara K

    更新日期:2006-01-01 00:00:00

  • Validation and comparison of CS-IHC4 scores with a nomogram to predict recurrence in hormone receptor-positive breast cancers.

    abstract::The aim of this study was to both develop and validate a nomogram based on the Ki-67 index to predict recurrence. We constructed a nomogram using the Cox proportional hazards model with 953 N0 and N1 postoperative hormone receptor (HR)-positive breast cancer patients and validated it in an external cohort of 895 patie...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000362281

    authors: Park YH,Im SA,Cho EY,Ahn JH,Woo SY,Kim S,Keam B,Lee JE,Han W,Nam SJ,Park IA,Noh DY,Yang JH,Ahn JS,Im YH

    更新日期:2014-01-01 00:00:00

  • Symptoms and causation of the planarian disease related to cancer.

    abstract::The disease provoked by injections of water and other harmless liquids or wounds without tissue loss, is characterized by the regression of certain organs, opening in the epidermis, pigmentary anomalies and malignant tumors. The very few worms which recover spontaneously, regenerate the eliminated parts or develop sup...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225055

    authors: Chandebois R

    更新日期:1975-01-01 00:00:00

  • VEGF as a key mediator of angiogenesis in cancer.

    abstract::Vascular endothelial growth factor (VEGF) is a homodimeric glycoprotein with a molecular weight of approximately 45 kDa. It is the key mediator of angiogenesis (the formation of new blood vessels), and binds two VEGF receptors (VEGF receptor-1 and VEGF receptor-2), which are expressed on vascular endothelial cells. In...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000088478

    authors: Carmeliet P

    更新日期:2005-01-01 00:00:00

  • Overcoming Tamoxifen Resistance by Regulation of Del-1 in Breast Cancer.

    abstract:BACKGROUND:Hormone receptor-positive breast cancer accounts for nearly two-thirds of breast cancer cases; it ultimately acquires resistance during endocrine treatment and becomes more aggressive. This study evaluated the role of developmental endothelial locus (Del)-1 in tamoxifen-resistant (TAM-R) breast cancer. METH...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000501340

    authors: Lee J,Jeong JH,Jung JH,Kim WW,Lee SJ,Park JY,Park JY,Kang SH,Kim EA,Park JH,Chae YS,Park HY

    更新日期:2019-01-01 00:00:00

  • Radioimmunoimaging in malignant melanoma with monoclonal antibodies.

    abstract::Twenty-five patients with cutaneous melanoma were imaged with F(ab')2 fragments of antimelanoma monoclonal antibody (MoAb) 225.28S labeled with 99mTc and 131I or 111In. Out of 16 patients without evidence of metastatic lesions, 6 false-positive cases were observed. Only 4 out of 9 patients with known lesions showed po...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226649

    authors: Repetto L,Scopinaro G,Michelotti A,Claudiani F,Fusco V,Grimaldi A,Sertoli MR,Rosso R

    更新日期:1988-01-01 00:00:00

  • Loss of p16/CDKN2A protein in Epstein-Barr virus-associated gastric carcinoma.

    abstract::We examined the expression of p16, the CDKN2A gene product, in EBV-associated gastric carcinomas (EBV-GCs). EBV-GCs were identified by detecting EBV-encoded small RNA (EBER) using an in situ hybridization assay of paraffin-embedded tissue. Two non-EBV-GC cases for each EBV-GC case were selected, matched for age, sex, ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000080290

    authors: Koriyama C,Kitajima S,Nomoto M,Sueyoshi K,Itoh T,Eizuru Y,Yonezawa S,Akiba S

    更新日期:2004-01-01 00:00:00

  • Creatinine clearance is associated with toxicity from molecularly targeted agents in phase I trials.

    abstract:OBJECTIVES:This study aimed to evaluate any correlations between baseline creatinine clearance and the development of grade 3/4 toxicities during treatment within oncology phase I trials of molecularly targeted agents where entry criteria mandate a serum creatinine of ≤ 1.5 × the upper limit of normal. METHODS:Documen...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000341152

    authors: Basu B,Vitfell-Pedersen J,Moreno Garcia V,Puglisi M,Tjokrowidjaja A,Shah K,Malvankar S,Anghan B,de Bono JS,Kaye SB,Molife LR,Banerji U

    更新日期:2012-01-01 00:00:00

  • Immunologic and immunohistochemical studies on chronic lymphocytic thyroiditis with or without thyroid lymphoma.

    abstract::The local immunologic phenomena in the thyroid gland of 16 patients with chronic lymphocytic thyroiditis (CLTH) were investigated; 5 of these cases were associated with thyroid non-Hodgkin's lymphomas (NHL). All patients were admitted because of struma, growing slowly in patients with CLTH alone and rapidly in those w...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226897

    authors: Aozasa K,Tajima K,Tominaga N,Katagiri S,Yonezawa T,Matsuzuka F,Kuma K,Sawada M

    更新日期:1991-01-01 00:00:00

  • Quercetin inhibits the action of 12-O-tetradecanoylphorbol-13-acetate, a tumor promoter.

    abstract::Quercetin, a mutagenic but noncarcinogenic flavonoid, inhibited the increased incorporation of inorganic phosphate into phospholipids of human embryo fibroblasts induced by 12-O-tetradecanoylphorbol-13-acetate (TPA), a potent tumor promoter. Quercetin also inhibited TPA-induced increases of sugar transport and RNA syn...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225805

    authors: Nishino H,Nishino A,Iwashima A,Tanaka K,Matsuura T

    更新日期:1984-01-01 00:00:00

  • Expression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitors.

    abstract::Aromatase inhibitor (AI) is widely used as an endocrine treatment in postmenopausal patients with hormone receptor-positive breast cancer. To identify useful prognostic factors for patients with metastatic breast cancer treated with AI therapy, we investigated the association between several hormone receptor-related f...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000319540

    authors: Motomura K,Ishitobi M,Komoike Y,Koyama H,Nagase H,Inaji H,Noguchi S

    更新日期:2010-01-01 00:00:00

  • Epirubicin is More Effective than Miriplatin in Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.

    abstract:BACKGROUND:Transcatheter arterial chemoembolization (TACE) is a standard therapy used in the treatment of intermediate hepatocellular carcinoma (HCC). Recently, balloon-occluded TACE (B-TACE) has been developed. PURPOSE:This study aimed to clarify the effects of B-TACE in patients with HCC, with a focus on which drug ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000492822

    authors: Shirono T,Iwamoto H,Niizeki T,Shimose S,Nakano M,Satani M,Okamura S,Noda Y,Kamachi N,Kuromatsu R,Sakai M,Nomiyama M,Kuwano T,Tanaka M,Koga H,Torimura T

    更新日期:2019-01-01 00:00:00

  • Association between Helicobacter pylori infection and pancreatic cancer.

    abstract:PURPOSE:In order to determine whether infection with Helicobacter pylori might be associated with pancreatic adenocarcinoma, we performed a study to compare the H. pylori seroprevalence rate between patients with pancreatic carcinoma and matched control subjects. PATIENTS AND METHODS:Blood samples from 92 patients wit...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000011830

    authors: Raderer M,Wrba F,Kornek G,Maca T,Koller DY,Weinlaender G,Hejna M,Scheithauer W

    更新日期:1998-01-01 00:00:00

  • Erlotinib versus pemetrexed for pretreated non-squamous non-small cell lung cancer patients in clinical practice.

    abstract:BACKGROUND/AIM:Erlotinib and chemotherapy have shown similar efficacy for pretreated non-small cell lung cancer (NSCLC) patients, but none of the large studies have selected patients based on histology. We present a retrospective single-center series of advanced non-squamous NSCLC patients treated with erlotinib or pem...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000346534

    authors: Zugazagoitia J,Puente J,González-Larriba JL,Manzano A,Sotelo M,Hernández S,Sanz J,Pérez P,Díaz-Rubio E

    更新日期:2013-01-01 00:00:00

  • The ultrastructure of a poorly differentiated adenocarcinoma of the human tuba uterina.

    abstract::A poorly differentiated adenocarcinoma of the human oviduct was studied by light and transmission electron microscopy. Cells contained abundant mitochondria, bound and free ribosomes, prominent Golgi's bodies and aggregates of membrane-bound dense bodies. The small glandular lumina with numerous microvilli were genera...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225135

    authors: Rorat E,Fenoglio C

    更新日期:1976-01-01 00:00:00

  • Clinicopathological features and prognostic significance of HER2 expression in gastric cancer.

    abstract:BACKGROUND:HER2 positivity is reported to be <20% in gastric cancer. Clinicopathological characteristics will be helpful to understand the biological features of HER2-positive gastric cancer. METHODS:A total of 813 gastric cancer patients who underwent HER2 testing between January 2005 and December 2010 were included ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000368555

    authors: Park JS,Rha SY,Chung HC,Jung M,Kim KH,Jun HJ,Kim H,An JY,Kim HI,Cheong JH,Hyung WJ,Noh SH,Kim HS

    更新日期:2015-01-01 00:00:00